Lee H, Kim Y, Lee S, Jung Y, Kim H, Kim T
Nucleic Acids Res. 2024; 52(22):13706-13722.
PMID: 39588763
PMC: 11662665.
DOI: 10.1093/nar/gkae1076.
Parfenyev S, Shabelnikov S, Tolkunova E, Barlev N, Mittenberg A
Int J Mol Sci. 2023; 24(12).
PMID: 37372954
PMC: 10297930.
DOI: 10.3390/ijms24129806.
Padeken J, Methot S, Gasser S
Nat Rev Mol Cell Biol. 2022; 23(9):623-640.
PMID: 35562425
PMC: 9099300.
DOI: 10.1038/s41580-022-00483-w.
Bonanomi M, Salmistraro N, Fiscon G, Conte F, Paci P, Bravata V
Cancers (Basel). 2021; 13(20).
PMID: 34680207
PMC: 8534001.
DOI: 10.3390/cancers13205058.
Birkhoff J, Huylebroeck D, Conidi A
Genes (Basel). 2021; 12(7).
PMID: 34356053
PMC: 8304685.
DOI: 10.3390/genes12071037.
DNA methylation is involved in the pathogenesis of osteoarthritis by regulating expression and CtBP-mediated signaling.
Sun X, Xiao L, Chen J, Chen X, Chen X, Yao S
Int J Biol Sci. 2020; 16(6):994-1009.
PMID: 32140068
PMC: 7053340.
DOI: 10.7150/ijbs.39945.
NAD-linked mechanisms of gene de-repression and a novel role for CtBP in persistent adenovirus infection of lymphocytes.
Dickherber M, Garnett-Benson C
Virol J. 2019; 16(1):161.
PMID: 31864392
PMC: 6925507.
DOI: 10.1186/s12985-019-1265-y.
Epigenetic re-wiring of breast cancer by pharmacological targeting of C-terminal binding protein.
Byun J, Park S, Yi D, Shin J, Gil Hernandez S, Hewitt S
Cell Death Dis. 2019; 10(10):689.
PMID: 31534138
PMC: 6751206.
DOI: 10.1038/s41419-019-1892-7.
The CtBP1-HDAC1/2-IRF1 transcriptional complex represses the expression of the long noncoding RNA GAS5 in human osteosarcoma cells.
Zhang X, Du K, Lou Z, Ding K, Zhang F, Zhu J
Int J Biol Sci. 2019; 15(7):1460-1471.
PMID: 31337976
PMC: 6643137.
DOI: 10.7150/ijbs.33529.
Analysis of the interactome of Schistosoma mansoni histone deacetylase 8.
Caby S, Pagliazzo L, Lancelot J, Saliou J, Bertheaume N, Pierce R
PLoS Negl Trop Dis. 2017; 11(11):e0006089.
PMID: 29155817
PMC: 5722368.
DOI: 10.1371/journal.pntd.0006089.
FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain development.
Sahu S, Tiwari N, Pataskar A, Zhuang Y, Borisova M, Diken M
Nat Commun. 2017; 8(1):1523.
PMID: 29142217
PMC: 5688138.
DOI: 10.1038/s41467-017-01366-x.
The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.
Blevins M, Huang M, Zhao R
Mol Cancer Ther. 2017; 16(6):981-990.
PMID: 28576945
PMC: 5458631.
DOI: 10.1158/1535-7163.MCT-16-0592.
Diversification of C. elegans Motor Neuron Identity via Selective Effector Gene Repression.
Kerk S, Kratsios P, Hart M, Mourao R, Hobert O
Neuron. 2017; 93(1):80-98.
PMID: 28056346
PMC: 5777325.
DOI: 10.1016/j.neuron.2016.11.036.
Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP).
Korwar S, Morris B, Parikh H, Coover R, Doughty T, Love I
Bioorg Med Chem. 2016; 24(12):2707-15.
PMID: 27156192
PMC: 4993153.
DOI: 10.1016/j.bmc.2016.04.037.
Wnt/β-Catenin Mediates AICAR Effect to Increase GATA3 Expression and Inhibit Adipogenesis.
Wang L, Di L
J Biol Chem. 2015; 290(32):19458-68.
PMID: 26109067
PMC: 4528110.
DOI: 10.1074/jbc.M115.641332.
Brinker possesses multiple mechanisms for repression because its primary co-repressor, Groucho, may be unavailable in some cell types.
Upadhyai P, Campbell G
Development. 2013; 140(20):4256-65.
PMID: 24086079
PMC: 3787763.
DOI: 10.1242/dev.099366.
E2F-7 couples DNA damage-dependent transcription with the DNA repair process.
Zalmas L, Coutts A, Helleday T, La Thangue N
Cell Cycle. 2013; 12(18):3037-51.
PMID: 23974101
PMC: 3875678.
DOI: 10.4161/cc.26078.
C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer.
Byun J, Gardner K
Int J Cell Biol. 2013; 2013:647975.
PMID: 23762064
PMC: 3671672.
DOI: 10.1155/2013/647975.
MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.
Rajabi H, Ahmad R, Jin C, Kosugi M, Alam M, Joshi M
J Biol Chem. 2012; 287(13):10703-10713.
PMID: 22318732
PMC: 3322974.
DOI: 10.1074/jbc.M111.323311.
Therapeutic targeting of C-terminal binding protein in human cancer.
Straza M, Paliwal S, Kovi R, Rajeshkumar B, Trenh P, Parker D
Cell Cycle. 2010; 9(18):3740-50.
PMID: 20930544
PMC: 3047800.
DOI: 10.4161/cc.9.18.12936.